secwatch.observer — SEC 8-K summary
======================================

Issuer:     BioAtla, Inc. (BCAB)
CIK:        0001826892
Form:       8-K
Filed at:   2024-05-17T23:59:59+00:00
Accession:  0000950170-24-061616
Event type: litigation
Sentiment:  neutral
Materiality: 0.35
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

BioAtla settles shareholder derivative suit, pays $350K in fees after bylaw reforms
--------------------------------------------------------------------------------

- Company paid $350,000 in attorneys' fees to settle claims over bylaw amendments imposing disclosure requirements on dissident director nominations.
- BioAtla amended bylaws on April 22, 2024, to address challenged provisions; company denies all wrongdoing.
- Delaware Court of Chancery closed the action on May 15, 2024, subject to filing notice to putative class.
- Plaintiff alleged directors breached fiduciary duties by adopting bylaw amendments on January 5, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1826892/000095017024061616/0000950170-24-061616-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1826892/000095017024061616/bcab-20240515.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-061616

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer